Keywords: Roche, Head of pRED, R&D, AstraZeneca, Senior executive team changes

Roche recruits US academic to spice up R&D; changes at AstraZeneca

Article | 16 January 2013

Print This

In a bid to invigorate its R&D productivity, Swiss drug major Roche (ROG: SIX) has appointed a well-known ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in